Phase II trial of trimetrexate in patients with advanced renal cell carcinoma. Clinical Community Oncology Program

Eur J Cancer Clin Oncol. 1989 Apr;25(4):753-4. doi: 10.1016/0277-5379(89)90215-0.
No abstract available

MeSH terms

  • Aged
  • Antineoplastic Agents / therapeutic use*
  • Carcinoma, Renal Cell / drug therapy*
  • Drug Evaluation
  • Folic Acid Antagonists / therapeutic use
  • Humans
  • Kidney Neoplasms / drug therapy*
  • Middle Aged
  • Quinazolines / therapeutic use*
  • Trimetrexate

Substances

  • Antineoplastic Agents
  • Folic Acid Antagonists
  • Quinazolines
  • Trimetrexate